| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | disordered domain specific binding | 5.58e-04 | 39 | 18 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 5.87e-04 | 40 | 18 | 2 | GO:0140662 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 8.49e-04 | 875 | 18 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 1.94e-03 | 73 | 18 | 2 | GO:0044183 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.13e-03 | 93 | 18 | 2 | GO:0097110 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 5.40e-03 | 123 | 18 | 2 | GO:0030165 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 5.66e-03 | 126 | 18 | 2 | GO:0051082 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 6.82e-03 | 441 | 18 | 3 | GO:0016887 | |
| GeneOntologyMolecularFunction | integrin binding | 1.07e-02 | 175 | 18 | 2 | GO:0005178 | |
| GeneOntologyCellularComponent | gamma-delta T cell receptor complex | 1.05e-05 | 6 | 18 | 2 | GO:0042106 | |
| GeneOntologyCellularComponent | growth cone | 1.14e-03 | 245 | 18 | 3 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.25e-03 | 253 | 18 | 3 | GO:0030427 | |
| MousePheno | abnormal pelvic girdle bone morphology | 1.34e-06 | 87 | 14 | 4 | MP:0004509 | |
| MousePheno | abnormal pelvic girdle joint morphology | 3.34e-05 | 9 | 14 | 2 | MP:0030819 | |
| MousePheno | abnormal hip joint morphology | 3.34e-05 | 9 | 14 | 2 | MP:0030829 | |
| MousePheno | abnormal girdle joint morphology | 8.42e-05 | 14 | 14 | 2 | MP:0030818 | |
| MousePheno | abnormal head movements | 1.33e-04 | 103 | 14 | 3 | MP:0000436 | |
| MousePheno | abnormal hindlimb joint morphology | 1.75e-04 | 20 | 14 | 2 | MP:0030808 | |
| MousePheno | abnormal limb joint morphology | 2.76e-04 | 25 | 14 | 2 | MP:0030805 | |
| MousePheno | abnormal stationary movement | 3.81e-04 | 147 | 14 | 3 | MP:0001388 | |
| MousePheno | decreased circulating sodium level | 5.75e-04 | 36 | 14 | 2 | MP:0005634 | |
| MousePheno | stereotypic behavior | 1.14e-03 | 214 | 14 | 3 | MP:0001408 | |
| Pubmed | Structure, organization, and somatic rearrangement of T cell gamma genes. | 2.83e-07 | 2 | 19 | 2 | 3917858 | |
| Pubmed | Allelic differences in TCR gamma-chains alter gamma delta T cell antigen reactivity. | 2.83e-07 | 2 | 19 | 2 | 8046225 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 1973682 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 3486244 | ||
| Pubmed | Physical linkage of mouse Tcrg-V genes. II. Regulatory features of the Vg4-Vg3 intergenic region. | 2.83e-07 | 2 | 19 | 2 | 8119740 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 8244371 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 14691262 | ||
| Pubmed | New T-cell receptor gamma haplotypes in wild mice and evidence for limited Tcrg-V gene polymorphism. | 2.83e-07 | 2 | 19 | 2 | 8420824 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 9126983 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 8550103 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 3871915 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 3375073 | ||
| Pubmed | Langerhans cells are not required for epidermal Vgamma3 T cell homeostasis and function. | 8.48e-07 | 3 | 19 | 2 | 21486908 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 2879283 | ||
| Pubmed | Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. | 2.82e-06 | 5 | 19 | 2 | 15821084 | |
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 30976362 | ||
| Pubmed | 5.93e-06 | 7 | 19 | 2 | 16288044 | ||
| Pubmed | 5.93e-06 | 7 | 19 | 2 | 16418397 | ||
| Pubmed | Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. | 5.93e-06 | 7 | 19 | 2 | 7477352 | |
| Pubmed | STAT5 is required for thymopoiesis in a development stage-specific manner. | 2.20e-05 | 13 | 19 | 2 | 15294943 | |
| Pubmed | HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3. | 2.56e-05 | 14 | 19 | 2 | 28739485 | |
| Pubmed | PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78. | 2.56e-05 | 14 | 19 | 2 | 29178343 | |
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 3.38e-05 | 16 | 19 | 2 | 16269234 | |
| Pubmed | 6.49e-05 | 22 | 19 | 2 | 2527426 | ||
| Pubmed | 1.76e-04 | 36 | 19 | 2 | 31669268 | ||
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 4.05e-04 | 269 | 19 | 3 | 30442662 | |
| Cytoband | 7p14 | 7.01e-05 | 30 | 19 | 2 | 7p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | 1.56e-03 | 566 | 19 | 3 | chr14q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p14 | 2.34e-03 | 174 | 19 | 2 | chr7p14 | |
| Cytoband | 14q32.33 | 3.97e-03 | 228 | 19 | 2 | 14q32.33 | |
| GeneFamily | T cell receptor gamma locus at 7p14 | 1.68e-04 | 22 | 16 | 2 | 375 | |
| Coexpression | AIZARANI_LIVER_C12_NK_NKT_CELLS_4 | 4.91e-06 | 49 | 18 | 3 | M39116 | |
| Coexpression | ROPERO_HDAC2_TARGETS | 5.91e-05 | 112 | 18 | 3 | M8759 | |
| ToppCell | tumor_Lung-T/NK_cells-Naive_CD8+_T|tumor_Lung / Location, Cell class and cell subclass | 6.32e-07 | 164 | 19 | 4 | a669d3b39dcd219a1973e266765e2f2b114438ef | |
| ToppCell | severe_influenza-gd_T|World / disease group, cell group and cell class (v2) | 7.13e-07 | 169 | 19 | 4 | 6d514dd2d1e5253bce49279f43aa2fa2b7c2653e | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-06 | 186 | 19 | 4 | d4be02813d590aa7ffe0d1553a27d257b9ab77fe | |
| ToppCell | (0)_T_CD8|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.16e-06 | 191 | 19 | 4 | 59b87beec2b12ad0a35d86f911423e3a0a3f4701 | |
| ToppCell | 367C-Lymphocytic|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-06 | 193 | 19 | 4 | b069a1cba2e1bf1c0d7479b11185fb416f18b14b | |
| ToppCell | (0)_NK/T_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.29e-06 | 196 | 19 | 4 | baee29014dc56c71a6ef790bb7ecd5b5271cfcb0 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm_gut_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.29e-06 | 196 | 19 | 4 | 528622874692d7d65c905738b078ab53acef5846 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.27e-05 | 108 | 19 | 3 | 04bfb90634b691020f246a8afbebd3bf944d1e0e | |
| ToppCell | tumor_Lung-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.81e-05 | 141 | 19 | 3 | f62d78b3f998f3ea493647c4c5b86cfec2243f0b | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.87e-05 | 142 | 19 | 3 | eaf08a0dbacc9ebbd54e377922e76d8ba854dcb8 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.19e-05 | 147 | 19 | 3 | 743767abdb3b5ecad870b617f515b037ce280818 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-05 | 148 | 19 | 3 | e7bbb5ddf44b11b8495e83863fbf1fd9f3f24472 | |
| ToppCell | MS-CD8-CD8_2|MS / Condition, Cell_class and T cell subcluster | 3.38e-05 | 150 | 19 | 3 | 01c20d787ce269db0d153e63a600a8d9ead61856 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.80e-05 | 156 | 19 | 3 | c11ca6b1b5029c15aab91273cece70a487287839 | |
| ToppCell | 367C-Lymphocytic-ILC|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.10e-05 | 160 | 19 | 3 | f70ec054b6d51c1565e4a257cbe3c9537c0eb09f | |
| ToppCell | Influenza_Severe-gd_T|World / Disease group and Cell class | 4.18e-05 | 161 | 19 | 3 | b3cdaed4d58d57e3c5dbc904a09388f3bf949407 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 4.41e-05 | 164 | 19 | 3 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-05 | 167 | 19 | 3 | c2a0fdb35ec48b956be0686534b29164db6638ab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.83e-05 | 169 | 19 | 3 | f06118754fa62c580b4bcbecff6f9e5fdc2106a0 | |
| ToppCell | Influenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class | 4.91e-05 | 170 | 19 | 3 | 59009c5a504ea8c6b4f6697299db219fd5edf7d6 | |
| ToppCell | URO-Lymphocyte-T_NK-gdT|URO / Disease, Lineage and Cell Type | 5.09e-05 | 172 | 19 | 3 | 97b1eb95234639fcaa5ea3c4ba7ec2f4eb929dbf | |
| ToppCell | primary_auditory_cortex_(A1C)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-05 | 172 | 19 | 3 | 20ea9db009370aa6235365ce93e153eb5b28db94 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-MAIT|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.09e-05 | 172 | 19 | 3 | 18bda0038cb37da6784e7bf7291272c108cfd9c5 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.17e-05 | 173 | 19 | 3 | b06d6e7acb7086bb99600b680cf404c0ef06b52c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.45e-05 | 176 | 19 | 3 | dbc4f64cd39b229f2355ca1d0215cc7f6a767dce | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.45e-05 | 176 | 19 | 3 | ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.54e-05 | 177 | 19 | 3 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class | 5.54e-05 | 177 | 19 | 3 | 34e9455790bae905dd91923792f4109d18b7686e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.54e-05 | 177 | 19 | 3 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.54e-05 | 177 | 19 | 3 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.54e-05 | 177 | 19 | 3 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 5.54e-05 | 177 | 19 | 3 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | IIF-Lymphocyte-T_NK-MAIT|IIF / Disease, Lineage and Cell Type | 5.63e-05 | 178 | 19 | 3 | be777ebef8f09a1a16fcee8fc69a65ab295b6e1d | |
| ToppCell | IIF-Lymphocyte-T_NK-gdT|IIF / Disease, Lineage and Cell Type | 5.63e-05 | 178 | 19 | 3 | 3344d1328fd9c570c3a4b2629edec627a442d0e0 | |
| ToppCell | ASK428-Immune-NK_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.82e-05 | 180 | 19 | 3 | 857d09446e3e6737e83d0f10bfda2ba282d5ba75 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.02e-05 | 182 | 19 | 3 | 8b8fd33e539e7e253c022481100223b17b279a73 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.02e-05 | 182 | 19 | 3 | 52baef8173df0a55307c375674a37c2488066738 | |
| ToppCell | severe_influenza-gd_T|severe_influenza / disease group, cell group and cell class (v2) | 6.02e-05 | 182 | 19 | 3 | b6b44c90af3f0c0dddb2b171087865d8c15a3973 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.11e-05 | 183 | 19 | 3 | 983ca1342ddd365e1f1df32a456394b002b10e41 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.21e-05 | 184 | 19 | 3 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.21e-05 | 184 | 19 | 3 | 5b4f18b26d03e8e5798cac70d124534749fc4cc0 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 6.21e-05 | 184 | 19 | 3 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN1_thymic_pro-T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.31e-05 | 185 | 19 | 3 | 5db31631a4b4c4bfeb28f02d8dab00a48d77bcba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.42e-05 | 186 | 19 | 3 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | Control-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 6.42e-05 | 186 | 19 | 3 | a8a4c0f4058f5bbc435dd2dd41d55383173a1358 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.52e-05 | 187 | 19 | 3 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | ILEUM-inflamed-(1)_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.52e-05 | 187 | 19 | 3 | a77d7ae44f47410bd92fb3aa0f44dce891752b63 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.52e-05 | 187 | 19 | 3 | 7375f70a970a5d5a58b7c33ada2dcf6dcef525c6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 6.62e-05 | 188 | 19 | 3 | 90188b60ff893754f7938fe8edab79758827168e | |
| ToppCell | (1)_T_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.73e-05 | 189 | 19 | 3 | fa6b85676b2b61483ae27720d0715dbfcbcfbdf9 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.73e-05 | 189 | 19 | 3 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Trm/em_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.73e-05 | 189 | 19 | 3 | 17733be6ead1d24149d478023f731d23876b4f54 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_gd|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.83e-05 | 190 | 19 | 3 | 268772d2adff34f7175b8474e95b67fd96dc1234 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.83e-05 | 190 | 19 | 3 | 4240d52a465bc3f8016834b22a35c44ba2b0a9f4 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.83e-05 | 190 | 19 | 3 | be281c7c717c11ef3c5cbccd22628acf1bd9727f | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 6.83e-05 | 190 | 19 | 3 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.94e-05 | 191 | 19 | 3 | db7b8f8826bf19d6eeee14319570a9e6e99ab2cb | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 191 | 19 | 3 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.94e-05 | 191 | 19 | 3 | c4a2a8a7b864df282546e6ac53fcb2269cbb3345 | |
| ToppCell | BLOOD--(1)_gd_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.94e-05 | 191 | 19 | 3 | 47ced00ed6fb47ddc6e9baa76186ea974720defd | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.05e-05 | 192 | 19 | 3 | a0bd4a0d00246af4f6645e66a0dedfe36882cc60 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-05 | 192 | 19 | 3 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-05 | 192 | 19 | 3 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | ILEUM-non-inflamed-(1)_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.05e-05 | 192 | 19 | 3 | a9f89043c97cd2b0ba165e69ee5681094410af37 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 7.16e-05 | 193 | 19 | 3 | 75a0b3aa40bdb844dc48c2b6ad945c73e47b60d4 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-05 | 193 | 19 | 3 | 544de0988510cc57744710d7cafe07aa27a0b99d | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Naive_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 7.16e-05 | 193 | 19 | 3 | 828f11c9081df74faf3b788456991e1a0cf99900 | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|World / disease group, cell group and cell class | 7.16e-05 | 193 | 19 | 3 | ddc1db516568e03be8e82b2ca770c67756418185 | |
| ToppCell | Influenza_Severe-CD8+_Tem|World / Disease group and Cell class | 7.16e-05 | 193 | 19 | 3 | fce6138712353fba14eb046e10d54e112372658e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.16e-05 | 193 | 19 | 3 | db9378c5bb5c27b321957a05dcabf40e97a3b725 | |
| ToppCell | Control-Lymphocyte-T_NK|Control / Disease, Lineage and Cell Type | 7.16e-05 | 193 | 19 | 3 | eb8b8f6e52fd140fbacf3d6776458c6fc355e120 | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 19 | 3 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.27e-05 | 194 | 19 | 3 | bf2480acec5612cd8a3c33d3e7a98176dc6c9091 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.27e-05 | 194 | 19 | 3 | 73c057b623829de793616d9d373a0018071d51d8 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 19 | 3 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-CD8_low_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.27e-05 | 194 | 19 | 3 | b0595b98332fee7936e455240bbefe72b79c98b8 | |
| ToppCell | URO-Lymphocyte-T_NK|URO / Disease, Lineage and Cell Type | 7.27e-05 | 194 | 19 | 3 | 4806c07dcf1bc6d9591548382b77817568eb16b6 | |
| ToppCell | BLOOD--(1)_MAIT-like_CD8_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.27e-05 | 194 | 19 | 3 | 0064bcd9ac2fecec81f8d4e7d9f86f0089872fe7 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.27e-05 | 194 | 19 | 3 | d548e5cdf669776e840cc3129969897abfffc211 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-05 | 194 | 19 | 3 | b571f5f021619df0eedda5dd6739673f41dfab61 | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 19 | 3 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 19 | 3 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-05 | 194 | 19 | 3 | a8dc3336aa4ef497f6d26cede02ddac425e7c655 | |
| ToppCell | BLOOD--(1)_EM_CTLs| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.27e-05 | 194 | 19 | 3 | 66583c6cff3814902d6babdea3a2ae962decde65 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|tumor_Lung / Location, Cell class and cell subclass | 7.27e-05 | 194 | 19 | 3 | 21d789585b3085aeeae3bef595c6cc5ea1c3dc4f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.38e-05 | 195 | 19 | 3 | 662b50a2aa97373bf343b88caace9717049c722a | |
| ToppCell | (1)_T_CD8_CTL|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.38e-05 | 195 | 19 | 3 | f582b854e5a4c52764aad5abe4e28ea77a7445f7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.38e-05 | 195 | 19 | 3 | 9b7157b5e4b81bc35b0e6d9b954279160ea57324 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.38e-05 | 195 | 19 | 3 | 974bb20df9756d322f8b7de92db262e26d629bfa | |
| ToppCell | normal_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 7.38e-05 | 195 | 19 | 3 | 3af8ea15e2ac8efdeb4d4f69357b83b8dbcfab8d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.38e-05 | 195 | 19 | 3 | acb3bb9a38c4c58547cccaf2c2aff14aef56c679 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 7.38e-05 | 195 | 19 | 3 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | (1)_T_CD8_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.38e-05 | 195 | 19 | 3 | 2253590339b87692d350f9ea3d2aa851179967e1 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.49e-05 | 196 | 19 | 3 | 3f5bf202c5d8c15072255c133793c8ee6e8d932f | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|World / Lineage, cell class and subclass | 7.49e-05 | 196 | 19 | 3 | 78b006922307c154622d71fcbc79ae5eed3f4b23 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Cytotoxic_CD8+_T|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.49e-05 | 196 | 19 | 3 | 6789c88a99cadfd8122ece4b736ba6783ae6e6f5 | |
| ToppCell | Influenza_Severe-CD8+_Tem|Influenza_Severe / Disease group and Cell class | 7.49e-05 | 196 | 19 | 3 | c2d31b2a560309264e846271430a846f09a73ef8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.49e-05 | 196 | 19 | 3 | 37065ac2c89a8b5ed52af9f796e0c97909ee51a4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.49e-05 | 196 | 19 | 3 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | severe-CD8+_Tem|World / disease stage, cell group and cell class | 7.49e-05 | 196 | 19 | 3 | b8156d31312660fe9c071cb10d7ef22af672c6c8 | |
| Drug | 1,2,4,7,8-pentachlorodibenzo-p-dioxin | 1.24e-05 | 7 | 18 | 2 | CID000042836 | |
| Drug | 9-phenanthrol | 1.65e-05 | 8 | 18 | 2 | CID000010229 | |
| Drug | 1,2-bis(2,4,6-tribromophenoxy)ethane | 2.65e-05 | 10 | 18 | 2 | ctd:C081014 | |
| Drug | gedunin | 3.80e-05 | 84 | 18 | 3 | ctd:C106014 | |
| Drug | steroid D | 4.58e-05 | 13 | 18 | 2 | CID000454475 | |
| Drug | CMV423 | 4.58e-05 | 13 | 18 | 2 | CID000489128 | |
| Drug | isopimpinellin | 6.16e-05 | 15 | 18 | 2 | CID000068079 | |
| Drug | racemethorphan | 7.82e-05 | 107 | 18 | 3 | CID000003008 | |
| Drug | DCDD | 1.00e-04 | 19 | 18 | 2 | CID000036613 | |
| Drug | nobiletin | 1.48e-04 | 23 | 18 | 2 | ctd:C008661 | |
| Drug | tripterine | 1.70e-04 | 139 | 18 | 3 | ctd:C050414 | |
| Drug | coumarin | 1.70e-04 | 139 | 18 | 3 | CID000000323 | |
| Drug | PeCDD | 2.05e-04 | 27 | 18 | 2 | CID000038439 | |
| Drug | imperatorin | 2.37e-04 | 29 | 18 | 2 | CID000010212 | |
| Drug | phenethyl isothiocyanate | 2.38e-04 | 401 | 18 | 4 | ctd:C058305 | |
| Drug | monamine | 3.07e-04 | 33 | 18 | 2 | CID000004034 | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.07e-04 | 170 | 18 | 3 | 3945_UP | |
| Drug | perfluorobutyric acid | 3.26e-04 | 34 | 18 | 2 | ctd:C033094 | |
| Drug | wortmannin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.35e-04 | 175 | 18 | 3 | 869_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.63e-04 | 180 | 18 | 3 | 1065_UP | |
| Drug | Humic Substances | 3.66e-04 | 36 | 18 | 2 | ctd:D006812 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.81e-04 | 183 | 18 | 3 | 1074_UP | |
| Drug | AC1L3O4Q | 3.87e-04 | 37 | 18 | 2 | CID000119057 | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.87e-04 | 184 | 18 | 3 | 1051_UP | |
| Drug | perfluorohexanoic acid | 4.08e-04 | 38 | 18 | 2 | ctd:C479228 | |
| Drug | Indoles | 4.30e-04 | 39 | 18 | 2 | ctd:D007211 | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; HL60; HG-U133A | 4.46e-04 | 193 | 18 | 3 | 1417_DN | |
| Drug | Sulpiride | 4.52e-04 | 40 | 18 | 2 | ctd:D013469 | |
| Drug | diclofenac sodium; Up 200; 10uM; MCF7; HG-U133A | 4.80e-04 | 198 | 18 | 3 | 333_UP | |
| Drug | 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione | 5.73e-04 | 45 | 18 | 2 | ctd:C020175 | |
| Drug | Albendazole | 5.99e-04 | 46 | 18 | 2 | ctd:D015766 | |
| Drug | enniatins | 6.52e-04 | 48 | 18 | 2 | ctd:C100264 | |
| Drug | felbamate | 6.52e-04 | 48 | 18 | 2 | ctd:C047360 | |
| Drug | 19-HETE | 6.79e-04 | 49 | 18 | 2 | CID006439528 | |
| Disease | Contact hypersensitivity | 9.51e-04 | 71 | 19 | 2 | C0162351 | |
| Disease | Contact Dermatitis | 9.51e-04 | 71 | 19 | 2 | C0011616 | |
| Disease | coffee consumption measurement | 6.04e-03 | 182 | 19 | 2 | EFO_0006781 | |
| Disease | Hypertensive disease | 6.56e-03 | 190 | 19 | 2 | C0020538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSFYVVMWKQMEQT | 606 | P49747 | |
| YWSSFMTSSMQLAKE | 116 | Q96BY7 | |
| TVTTAISWSLMYLVM | 321 | P04798 | |
| RYMQWRETMSSTSTL | 536 | Q96DU7 | |
| MSSSMWYIMQSIQSK | 1 | Q9H765 | |
| MISSTSVYGLKMQWT | 1 | Q5HY92 | |
| TSTYSWTANMEQIMK | 366 | Q58FF8 | |
| QMGSMTSTTLYNSMW | 596 | O43424 | |
| WVTMTRDTSISTAYM | 86 | P23083 | |
| YDPKTDMWTAVASMS | 681 | Q96PQ7 | |
| SQKMPTSWLAEMTSS | 181 | P78310 | |
| TSTYGWTANMERIMK | 601 | P07900 | |
| TWVLNTYTSTEMMRN | 341 | O60645 | |
| TQYKMTISMADWPSE | 451 | P51168 | |
| KTHYSMDSLSSWYMT | 176 | Q9UBD5 | |
| MDSLSSWYMTVTQKT | 181 | Q9UBD5 | |
| NTMKTNDTYMKFSWL | 61 | P0CF51 | |
| NTMKTNDTYMKFSWL | 61 | P03986 | |
| ITYEKMVAWSSSENM | 276 | Q96P63 | |
| TSSMASRTSSEMSWV | 306 | Q9H3M7 |